ANAB Stock Summary and Trading Ideas (Anaptysbio | NASDAQ:ANAB)

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

Anaptysbio trades on the NASDAQ stock market under the symbol ANAB.

As of September 29, 2026, ANAB stock price declined to $50.37 with 644,594 million shares trading.

ANAB has a beta of 0.86, meaning it tends to be less sensitive to market movements. ANAB has a correlation of 0.02 to the broad based SPY ETF.

ANAB has a market cap of $1.51 billion. This is considered a Small Cap stock.

Last quarter Anaptysbio reported $27 million in Revenue and -$.11 earnings per share. This beat revenue expectation by $6 million and exceeded earnings estimates by $.35.

In the last 3 years, ANAB traded as high as $72.36 and as low as $6.11.

The top ETF exchange traded funds that ANAB belongs to (by Net Assets): VTI, XBI, IWM, VXF, IBB.

ANAB has outperformed the market in the last year with a return of +332.9%, while the SPY ETF gained +16.3%. However, in the most recent history, ANAB shares have underperformed the stock market with its stock returning -23.6% in the last 3 month period and -7.9% for the last 2 week period, while SPY has returned +3.4% and +1.1%, respectively.

ANAB support price is $49.46 and resistance is $52.14 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ANAB shares will trade within this expected range on the day.